• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,716.35(%)
  • Trent
    2,815.00 3,497.35(%)
  • Raymond
    1,024.00 1,024.00(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 530.65(%)
  • One 97
    1,829.50 1,829.50(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,727.35(%)
  • Britannia Inds.
    4,946.05 4,946.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vista Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4316.0
  • ISIN : INE427C01021
5.75 0 (2.68%)
  • As on 13 Sep 2026 (EOD)

  • Today’s Low

    5.50

  • Today’s High

    5.80

  • Open

    5.60

  • Perv Close

    5.60

  • 52W Low

    5.50

  • 52W High

    10.50

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    35.39

  • Div & Yield %

    0.00

  • Book Value(₹)

    5.92

  • Debt-Equity Ratio

    2.68

  • AGM Date

    11-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    35.39

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    12.31

  • BV (₹)

    5.90

  • Sales( ₹ in Cr.)

    5.40

  • NP (in Cr.)

    -12.06

  • NP Var(%)

    -159.0

  • Div%

    0.0

  • CPS (₹)

    -1.80

  • EPS (₹)

    -2.00

  • Traded Value (₹ in Lakhs)

    35.39

  • 52 Week High

    10.50

  • 52 Week Low

    5.50

  • Price BSE

    6.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    35.39

  • P/C Ratio

    -3.30

  • P/E Ratio

    -3.10

  • Price Vs.BV

    -2.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 10.07 10.29 1.00 0.39 1.27 22.76
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 10.07 10.29 1.00 0.39 1.27 22.76
Other Income 0.44 0.33 0.40 0.17 0.20 3.75
Stock Adjustments -0.45 -0.01 0.00 0.00 0.00 -1.04
Total Income 10.06 10.61 1.40 0.56 1.47 25.47
EXPENDITURE :            
Raw Materials 7.90 8.88 2.83 0.37 0.73 22.90
Power and Fuel Cost 0.49 0.57 0.23 0.22 0.28 0.39
Employee Cost 2.00 1.79 0.51 0.57 1.15 1.31
Other Manufacturing Expenses 0.89 1.06 0.19 0.07 0.21 0.48
Selling and Administration Expenses 2.21 1.15 0.51 0.37 0.60 1.12
Miscellaneous Expenses 0.16 0.38 1.05 0.07 0.03 0.32
Employee Benefit Expenses 2.00 1.79 0.51 0.57 1.15 1.31
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 13.65 13.83 5.32 1.67 3.00 26.52
Operating Profit -3.58 -3.22 -3.92 -1.10 -1.53 -1.05
Interest 0.97 1.24 1.34 0.90 1.55 1.54
Gross Profit -4.55 -4.46 -5.26 -2.00 -3.08 -2.59
Depreciation 0.74 0.72 0.62 0.62 0.73 1.35
Profit Before Tax -5.29 -5.18 -5.88 -2.62 -3.81 -3.94
Current Tax 0.43 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.07 -0.67 -0.21 -1.73 -1.80 -0.26
Reported Net Profit -4.65 -4.51 -5.66 -0.89 -2.01 -3.68
Extraordinary Items 0.00 -0.26 0.00 0.00 0.00 0.00
Adjusted Net Profit -4.65 -4.25 -5.66 -0.89 -2.01 -3.68
Adjustment below Net Profit 0.00 0.00 0.00 3.51 -3.79 0.00
P & L Balance brought forward -10.62 -6.11 -0.45 -3.06 2.73 6.41
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -15.27 -10.62 -6.11 -0.45 -3.06 2.73
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.76 -0.96 -1.51 -0.24 -0.55 -1.21
Earnings Per Share(Adj)-Unit Curr -0.76 -0.96 -1.51 -0.24 -0.55 -1.21
Book Value 7.38 7.56 8.13 9.64 8.93 9.76
Book Value(Adj)-Unit Curr 7.38 7.56 8.13 9.64 8.93 9.76

Shareholding Pattern

  • Promoter Group

    21.19%

  • Public Share Holding

    78.81%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 5,710,567 5,710,567.00 5,710,567 5,710,567
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 5,710,567 9.28 5,710,567 5
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 6,579,620 10.69 6,579,620 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 750,000 1.22 750,000 1
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,329,620 11.91 7,329,620 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 166 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 14,166 0.02 0 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 14,332 0.02 0 5
2] Non Institution
Bodies Corporate 335,487 0.55 284,443 55
Clearing Members 1,680 0.00 1,680 2
Directors of their Relatives 24,297,365 39.47 24,297,365 4
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,132,133 5.09 1,853,280 101
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 11,630,267 18.90 11,630,267 15
Individuals holding nominal share capital up to Rs. 1 lakh 9,066,963 14.73 7,781,621 13,963
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 33,493 0.05 33,493 2
Others 0 0.00 0 0
Sub Total 48,497,388 78.79 45,882,149 14,142
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 61,551,907 100.00 58,922,336 14,154

Company Background

Vista Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Vista Pharmaceuticals Ltd
  • BSE Code : 4316.0
  • ISIN : INE427C01021

  • Incorporation Year

    1991

  • Registered Office

    Plot No 10to14 16to20 APIIC
    Industrial Estate Chotyal, Nalgonda,
    Telangana-

  • Telephone

    91-09291015956

  • FAX

    91-08682-272551

  • Chairman

    Dhananjaya Alli

  • Managing Director

  • Company Secretary

    Barkha Jain

  • Auditor

    A M Reddy & D R Reddy

  • Face Value

    2

  • Listing

    BSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285,
    Domalguda,J B Apartments
    Mumbai - Hyderabad - 500 029

Vista Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vista Pharma. 5.75 10.52 10.07 -3.01 0.00
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77